Free Trial

Merck & Co., Inc. (MRK) Stock Forecast & Price Target

$127.99
+0.49 (+0.38%)
(As of 06/18/2024 ET)

Merck & Co., Inc. - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$133.00
3.91% Upside
High Forecast$155.00
Average Forecast$133.00
Low Forecast$104.00
TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
10 Buy rating(s)
16 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$133.00$131.33$129.14$120.75
Forecasted Upside3.91% Upside10.85% Upside10.74% Upside13.66% Upside
Get Merck & Co., Inc. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

MRK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MRK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Merck & Co., Inc. Stock vs. The Competition

TypeMerck & Co., Inc.Medical CompaniesS&P 500
Consensus Rating Score
2.69
2.70
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside3.91% Upside1,068.20% Upside11.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Chen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00+21.55%
6/5/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Hellweg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/26/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$142.00 ➝ $143.00+8.80%
4/8/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$140.00 ➝ $143.00+11.73%
3/27/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$130.00 ➝ $135.00+7.54%
3/11/2024Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Sell$104.00-15.33%
2/2/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$135.00 ➝ $148.00+16.95%
2/2/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$135.00 ➝ $145.00+14.70%
1/4/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$125.00 ➝ $135.00+17.63%
11/9/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$115.00+10.15%
10/27/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$115.00 ➝ $118.00+12.19%
10/27/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$132.00+25.04%
7/14/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$123.00+15.70%
4/16/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
4/13/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$105.00 ➝ $130.00+14.29%
4/11/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$123.00 ➝ $124.00+10.11%
4/10/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mara Goldstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$130.00+15.44%
3/7/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$122.00 ➝ $127.00+14.14%
3/7/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$125.00 ➝ $126.00+13.24%
3/6/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$125.00+16.95%
2/23/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$120.00 ➝ $125.00+13.08%
2/22/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform$127.00+16.44%
2/3/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$120.00 ➝ $122.00+17.92%
1/4/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$110.00 ➝ $130.00+16.97%
1/3/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$108.00 ➝ $120.00+8.16%
8/25/2022Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
7/6/2022Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$89.00 ➝ $102.00+10.10%
6/27/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$95.00 ➝ $102.00+9.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:08 AM ET.

MRK Forecast - Frequently Asked Questions

What is Merck & Co., Inc.'s stock forecast and purchase recommendation?

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Merck & Co., Inc. is $133.00, with a high forecast of $155.00 and a low forecast of $104.00. The consensus rating for Merck & Co., Inc. stock is Moderate Buy based on the current 1 sell rating, 3 hold ratings, 8 buy ratings and 1 strong buy rating for MRK. Learn more on MRK's analyst rating history.

Do Wall Street analysts like Merck & Co., Inc. more than its competitors?

Analysts like Merck & Co., Inc. less than other "medical" companies. The consensus rating score for Merck & Co., Inc. is 2.69 while the average consensus rating score for "medical" companies is 2.70. Learn more on how MRK compares to other companies.

Is Merck & Co., Inc. being upgraded by Wall Street analysts?

Over the previous 90 days, Merck & Co., Inc.'s stock had 1 upgrade by analysts.

Does Merck & Co., Inc.'s stock price have much upside?

According to analysts, Merck & Co., Inc.'s stock has a predicted upside of 12.04% based on their 12-month stock forecasts.

What analysts cover Merck & Co., Inc.?

Merck & Co., Inc. has been rated by research analysts at Argus, Berenberg Bank, Cantor Fitzgerald, Truist Financial, and Wells Fargo & Company in the past 90 days.


Stock Forecasts and Research Tools

This page (NYSE:MRK) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners